Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 3.90 BATS BZX Real-Time Price As of 9:52am ET |  +0.05 / +1.30%Today’s Change | 3.39 Today|||52-Week Range 9.06 | -32.06% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for Cymabay Therapeutics Inc.
Today’s Trading
| Previous close | 3.85 |
| Today’s open | 3.81 |
| Day’s range | 3.81 - 3.91 |
| Volume | 441 |
| Average volume (3 months) | 590,800 |
| Market cap | $265.6M |
Data as of 9:52am ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | +51.74% |
| Earnings growth (this year) | -44.74% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DITAMCON Distributing C... | +0.86 | +0.56% |
| ---- | ||
| OPMZ1PM Industries Inc | 0.00 | 0.00% |
| PXRBPixarbio Corp | 0.00 | 0.00% |
Data as of 1:29pm ET, 09/17/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
